Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX)

Price 7.75p on 22-11-2024 at 16:55:03
Change 0.00p 0%
Buy 8.00p
Sell 7.50p
Buy / Sell RENX Shares
Last Trade: Unknown 300,000.00 at 7.425p
Day's Volume: 643,791
Last Close: 7.75p
Open: 7.75p
ISIN: GB00BYWL4Y04
Day's Range 7.50p - 7.75p
52wk Range: 7.25p - 60.00p
Market Capitalisation: £26m
VWAP: 7.455096p
Shares in Issue: 334m

Recent Trades History Renalytix Plc (RENX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 300,000 7.425p Ordinary
15:37:36 - 22-Nov-24
Unknown* -30,000 7.425p Ordinary
Correction
15:37:36 - 22-Nov-24
Sell* 30,000 7.425p Ordinary
15:37:36 - 22-Nov-24
Sell* 125,000 7.489p Ordinary
14:02:03 - 22-Nov-24
Sell* 12,195 7.15p Ordinary
12:40:18 - 22-Nov-24
Sell* 2,207 7.15p Ordinary
12:15:54 - 22-Nov-24
Sell* 8,875 7.50p Ordinary
12:07:51 - 22-Nov-24
Sell* 163,889 7.50p Ordinary
11:34:03 - 22-Nov-24
Sell* 31,360 7.50p Ordinary
11:01:11 - 22-Nov-24
Sell* 265 7.525p Ordinary
10:15:30 - 22-Nov-24

Share Price History for Renalytix Plc

Time period:
to
Date Open High Low Close Volume

Share News for Renalytix Plc

UK shareholder meetings calendar - next 7 days

24th Oct 2024 14:22

Read More

Renalytix rises amid well supported fund raise; narrowed annual loss

1st Oct 2024 15:53

(Alliance News) - Renalytix PLC on Tuesday announced a successful fund raise alongside a narrowed annual loss. Read More

LONDON MARKET CLOSE: Oil price hurts FTSE and investors dial out of BT

20th Aug 2024 16:59

(Alliance News) - Falling oil prices which knocked share prices of index heavyweights, BP and Shell, plus a sharp drop in BT, weighed on London's blue-chip index on Tuesday. Read More

IN BRIEF: Renalytix ends sale process without offer; considers funding

20th Aug 2024 13:15

Renalytix PLC - London-based in vitro diagnostics for kidney disease - Shares fall as Renalytix ends the formal sale process it launched back in March without an offer. Based on its discussions to date, the board doesn't think there is a "realistic prospect" of a takeover offer in the "near term". Renalytix says it is in talks with "key stakeholders" in the company about "a suitable capital structure and funding". Cash runway extends into the fourth quarter of this year based on its cash position of USD4.7 million on June 30. Read More

EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows

28th Jun 2024 19:46

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,262.08
Change112.81

Login to your account

Forgot Password?

Not Registered